acetyl l carnitine beneficii Acetyl L-Carnitine 500mg, 60 capsule,

10.1038/35046196 6 AsherB

Get the facts behind the news, plus analysis from multiple perspectives

Patients involved in this meta-analysis were from China, Finland, France, India, Japan, Netherlands, and United States

INOV2a, ACAGTTGTAAGGGATCTTGTGGCTGTCAGGATGGCAGAGGAGCAGGAGTTCACCCAGC jCG 105757-01 TCTGCAAGTTGCCTGCACAGCCCTCACACCCACACTGCGTGAACAACACCTACCGCAG DNA Sequence CGCACAGCACTCCCAGGCTCTGCTCCGAGGGCTGCTGGCTCTCCGGGACAGCGGAATC CTCTTCGATGTTGTGCTGGTGGTGGAGGGCAGACACATCGAGGCCCATCGCATCCTGC TGGCTGCGTCCTGCGATTACTTCAGGAGAGGAATGTTTGCTGGGGGATTGAAGGAGAT GGAACAGGAAGAGGTCCTGATCCACGGTGTGTCCTACAATGCTATGTGCCAAATCCTA CATTTCATATACACCTCCGAGCTGGAGCTCAGCCTGAGCAATGTACAAGAGACACTGG TGGCTGCCTGCCAGCTGCAGATCCCAGAAATTATCCATTTCTGCTGTGATTTCCTCAT GTCCTGGGTGGACGAAGAGAACATTCTCGATGTCTACCGGCTGGCAGAGCTGTTTGAC TTGAGCCGCCTGACTGAGCAACTGGACACCTATATCCTCAAAAACTTTGTGGCCTTCT CTCGGACTGACAAGTACCGCCAGCTTCCATTGGAGAAGGTCTACTCCCTCCTCAGCAG CAATCGCCTGGAGGTCTCCTGCGAGACCGAGGTATATGAGGGGGCCCTTCTCTACCAT TATAGCCTGGAGCAGGTGCAGGCTGACCAGATCTCGCTGCACGAGCCCCCAAAGCTCC TTGAGACAGTGCGGTTTCCGCTGATGGAAGCTGAGGTCCTGCAGCGGCTGCATGACAA GCTGGACCCCAGCCCTTTGAGGGACACAGTGGCCAGCGCCCTCATGTACCACCGGAAC GAGAGCCTACAGCCCAGCCTGCAGAGCCCGCAAACGGAGCTGCGGTCGGACTTCCAGT GCGTTGTGGGCTTCGGGGGCATTCACTCCACGCCGTCCACTGTCCTCAGCGACCAGGC CAAGTATCTAAACCCCTTACTGGGAGAGTGGAAGCACTTCACTGCCTCCCTGGCCCCC CGCATGTCCAACCAGGGCATCGCGGTGCTCAACAACTTCGTATACTTGATTGGAGGGG ACAACAATGTCCAAGGATTTCGAGCAGAGTCCCGATGCTGGAGGTATGACCCACGGCA CAACCGCTGGTTCCAGATCCAGTCCCTGCAGCAGGAGCACGCCGACCTGTCCGTGTGT GTTGTAGGCAGGTACATCTACGCTGTGGCGGGCCGTGACTACCACAATGACCTGAATG CTGTGGAGCGCTACGACCCTGCCACCAACTCCTGGGCATACGTGGCCCCACTCAAGAG GGAGGTAGTGTATGCCCACGCAGGCGCGACGCTGGAGGGGAAGATGTATATCACCTGC GGCCGCAGAGGGGAGGATTACCTGAAAGAGACACACTGCTACGATCCAGGCAGCAACA CTTGGCACACACTGGCTGATGGGCCTGTGCGGCGCGCCTGGCACGGCATGGCAACCCT CCTCAACAAGCTGTATGTGATCGGGGGCAGCAACAACGATGCCGGATACAGGAGGGAC GTGCACCAGCTCCCAGGTGCCCACGTGCTGCGCTGGCTGGAGGCAGCAAGGGGACGAG TGTGGGATTGCGGTGTGCGAAGGCAACTCCACGTGCTCAGAGAACGAGGTGTGCGTGA^ GGCCTGGCGAGTGCCGCTGCCGCCACGGCTACTTCGGTGCCAACTGCGACACCAGTGT GGCCAGTGCAAGGGGCCAGCAGCCGTGCACGGTGGCCGAGGGCCGCTGCTTGACGTGC GAGCCCGGCTGGAACGGAACCAAGTGCGACCAGCCTTGCGCCACCGGTTTCTATGGCG AGGGCTGCAGCCACCGCTGTCCGCCATGCCGCGACGGGCATGCCTGTAACCATGTCAC CGGCAAGTGTACGCGCTGCAACGCGGGCTGGATCGGCGACCGGTGCGAGACCAAGTGT AGCAATGGCACTTACGGCGAGGACTGCGCCTTCGTGTGCGCCGACTGCGGCAGCGGAC ACTGCGACTTCCAGTCGGGGCGCTGCCTGTGCAGCCCTGGCGTCCACGGGCCCCAGTG AGTGCCCCGGGACCGGGAGGGGGTTGGGGGCTTGTACCTGCCACAGAGGGGGGTCCAG CCGACGAGGTGGCCTCTCCACCCTGAGCTGGGTTATCACCTCAGCCTTGGTCCCTTAC CCCAGCTAGGGAGTGACAGTAGGCTCTTTGGGGGCAGTTTCCTGCCTGGATGTCGGGG jAGC'fCACGTTCAGCGCAGGATCTGGTGACCAGTCCAGCCTGTGTCAGTGGGCTCTTAA GGTGACCCCGAGTTGGTACAGAAGGACCAGGGACCTCCACTTACAGCCAAGGGTCTGG TTCAGCAGCCCCTCTTCCCACCTAGCCGAGTCAGCCCCAGCAGTGGGCGCTGCGGCGC GGCCACCACGGGTCCTATCCCCCAGGCCCCCCCACTAGTGTTGTGCAACATTCGTTTC CAAAACATCCACTACCCAATATGTGCC ORF Start: ATG at 31 ORF Stop: TAA at 1903 SEQ ID NO: 16 624 aa MWat 71369.7 Da lNOV2a, MAEEQEFTQLCKLPAQPSHPHCVNNTYRSAQHSQALLRGLLALRDSGILFDWLWEG JCG105757-01 RHIEAHRILLAASCDYFRRGMFAGGLKEMEQEEVLIHGVSYNA CQILHFIYTSELEL iProtein Sequence SLSNVQETLVAACQLQIPEIIHFCCDFLMS*WVDEENILDVYRLAELFDLSRLTEQLDT YILKNFVAFSRTDKYRQLPLEKVYSLLSSNRLEVSCETEVYEGALLYHYSLEQVQADQ ISLHEPPKLLETVRFPLMEAEVLQRLHDKLDPSPLRDTVASALMYHRNESLQPSLQSP QTELRSDFQCWGFGGIHSTPSTVLSDQAKYLNPLLGEWKHFTASLAPRMSNQGIAVL NNFVYLIGGDNNVQGFRAESRC RYDPRHNR FQIQSLQQEHADLSVCVVGRYIYAVA GRDYHNDLNAVERYDPATNSWAYVAPLKREWYAHAGATLEGKMYITCGRRGEDYLKE THCYDPGSNTWHTLADGPVRRAWHG ATLLNKLYVIGGSNNDAGYRRDVHQLPGAHVL R LEAARGRVDCGVRRQLHVLRERGVREA RVPLPPRLLRCQLRHQCGQCKGPAAVH GGRGPLLDVRARLERNQVRPALRHRFLWRGLQPPLSAMPRRACL Further analysis of the NOV2a protein yielded the following properties shown in Table 2B